Silk Road Medical, Inc (SILK) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
1213 Innsbruck Drive
Sunnyvale, CA 94089
United States of America (the)
Phone
408 720 9002
Website
Sector
Healthcare
Industry
Medical - Devices
Employees
474
First IPO Date
April 04, 2019
| Name | Title | Pay | Year Born |
| Charles S. McKhann | Chief Executive Officer & Director | 300,775 | 1969 |
| Richard Ruedy | Executive Vice President of Clinical, Regulatory Affairs & Quality Assurance | 476,274 | 1967 |
| Kevin Klemz | Executive Vice President, Chief Legal Officer & Secretary | 665,339 | 1961 |
| Lucas W. Buchanan | Chief Financial Officer & Chief Operating Officer | 836,870 | 1978 |
| Andrew S. Davis | Chief Commercial Officer | 1.2M | 1969 |
| Erica J. Rogers | Independent Consultant | 1.43M | 1963 |
| Jorge O'Hara | Vice President of Marketing, Business Development & Strategy | 0 | N/A |
| Alison Highlander | Vice President of Human Resources | 0 | N/A |
| Tammy Leitsinger | Compliance Officer & Vice President of Medical Affairs | 0 | N/A |
| Mhairi L. Jones | Chief Accounting Officer & Vice President of Finance | 0 | 1971 |
| Sumaira MacDonald | Executive Medical Director | 0 | N/A |
Silk Road Medical, Inc. operates as an American medical device company, focusing on innovative solutions for carotid artery disease. The firm's product portfolio is specifically engineered to support transcarotid artery revascularization (TCAR) procedures. Among its key offerings is the ENROUTE Transcarotid Neuroprotection System, designed to directly access the common carotid artery and initiate a temporary reversal of blood flow. The company also provides the ENROUTE Transcarotid Stent System, a distinctive stent characterized by its self-expanding and self-tapering capabilities. For streamlined initial entry to the common carotid artery, Silk Road Medical offers the ENHANCE Transcarotid Peripheral Access Kit. Additionally, the ENROUTE 0.014 Guidewire plays a crucial role in navigating and crossing target lesions, enabling the precise delivery of other interventional devices. Founded in 2007, Silk Road Medical, Inc. maintains its primary corporate offices in Sunnyvale, California.